Benzinga

Benzinga Korea 한국

Benzinga

Benzinga Korea 한국

Benzinga

Benzinga Korea 한국
목요일, 8월 20

Galmed Pharmaceuticals Ltd

GLMDNASDAQ
Trade with Public
Trade with Public
$4.77
가까이에: Aug 20, 5:00 PM EST
$4.50
-0.27-5.66%
시간외: 7:34 PM EST
PRO
변동 이유?:Galmed Pharmaceuticals shares are trading higher after the company's subsid...
주식 분할: Galmed Pharmaceuticals Ltd는 최근 분할했습니다. Wednesday, August 19, 2026 비율로 1:8
개요뉴스실적 전망목표가재무심리비교주식 보고서

Galmed Pharmaceuticals Financials

Galmed Pharmaceuticals (GLMD) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Galmed Pharmaceuticals Q3 EPS $(0.33) Beats $(0.54) Estimate

Galmed Pharmaceuticals (NASDAQ:GLMD) reported quarterly losses of $(0.33) per share which beat the analyst consensus estimate of $(0.54) by 38.89 percent. This is a 85.71 percent increase over losses of $(2.31) per share
Benzinga Newsdesk

PRO
Galmed Pharmaceuticals Q2 EPS $(0.63) Beats $(0.83) Estimate

Galmed Pharmaceuticals (NASDAQ:GLMD) reported quarterly losses of $(0.63) per share which beat the analyst consensus estimate of $(0.83) by 24.1 percent. This is a 61.82 percent increase over losses of $(1.65) per share
Benzinga Newsdesk

PRO
Galmed Pharmaceuticals Q1 EPS $(0.62) Beats $(0.89) Estimate

Galmed Pharmaceuticals (NASDAQ:GLMD) reported quarterly losses of $(0.62) per share which beat the analyst consensus estimate of $(0.89) by 30.34 percent. This is a 70.48 percent increase over losses of $(2.10) per share
Benzinga Newsdesk

Crude Oil Down 2%; Roper Technologies Increases 2025 Outlook

Avi Kapoor

Dow Jumps Over 150 Points; Domino's Pizza Posts Upbeat Earnings

Avi Kapoor

Gold Edges Lower; US Homebuilder Sentiment Rises For September

Avi Kapoor

데이터 및 API: Benzinga API · 주식 뉴스 API · 애널리스트 등급 API · 회사 로고 API

Benzinga

Benzinga Korea 한국

뉴스

파트너 / 기고자

벤징가 글로벌

© 2026 Benzinga | All Rights Reserved